Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03685331
Brief Title: HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

First Submitted : September 18, 2018
First Submitted that Met QC Criteria : September 24, 2018
First Posted : September 26, 2018

Last Update Submitted that Met QC Criteria : February 25, 2021
Last Update Posted : March 1, 2021